Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Degardin, M
Bastit, P
Rolland, F
Armand, JP
Chevallier, B
VanGlabbeke, M
Boudillet, J
Tresca, P
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：843 / 843
页数：1
相关论文
共 50 条
  • [21] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
  • [22] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
  • [23] Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens
    Massa, Elena
    Dessi, Mariele
    Gaspardini, Giulio
    Saba, Federica
    Cherchi, Valeria
    Mantovani, Giovanni
    ORAL ONCOLOGY, 2010, 46 (11) : 818 - 821
  • [24] Phase II trial of irinotecan (Ir) plus cisplatin (CDDP) in patients with recurrent or metastatic squamous carcinoma of the head and neck (SCCHN)
    Gilbert, J.
    Cmelak, A.
    Burkey, B.
    Sinard, R.
    Yarborough, W.
    Netterville, J.
    Paty, V.
    Chung, C.
    Hudson, T.
    Murphy, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    Couteau, C
    Chouaki, N
    Leyvraz, S
    Oulid-Aissa, D
    Lebecq, A
    Domenge, C
    Groult, V
    Bordessoule, S
    Janot, F
    De Forni, M
    Armand, JP
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 457 - 462
  • [26] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    C Couteau
    N Chouaki
    S Leyvraz
    D Oulid-Aissa
    A Lebecq
    C Domenge
    V Groult
    S Bordessoule
    F Janot
    M De Forni
    J-P Armand
    British Journal of Cancer, 1999, 81 : 457 - 462
  • [27] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
  • [28] Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients
    Barth, Claire
    Naveau, Louise
    Touboul, Emmanuel
    Perie, Sophie
    Bamogho, Edith
    Haberer-Guillerm, Sophie
    Schlienger, Michel
    St Guily, Jean Lacau
    Huguet, Florence
    ANTI-CANCER DRUGS, 2016, 27 (04) : 349 - 352
  • [29] Final results of a phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).
    Blumenschein, George R.
    Glisson, Bonnie S.
    Lu, Charles
    Sabichi, Anita Lyn
    Ginsberg, Lawrence E.
    Bartos, Claudia I.
    Feng, Lei
    Tran, Hai T.
    El-Naggar, Adel K.
    Lippman, Scott Michael
    Kies, Merrill S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] The triplet docetaxel, carboplatin and capecitabine in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN).
    Kattan, J
    Farhat, F
    Chahine, G
    Nasr, F
    Moukadem, W
    Younes, F
    Ghosn, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 521S - 521S
12345